Financial Statements — CCIX
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 1.55 | 1.67 | 0.00 |
| Total Current Assets | 0.28 | 0.47 | 0.85 | 2.72 | 1.99 | 2.14 | -- |
| Total Non-current Assets* | 310.26 | 304.54 | 302.30 | 299.16 | 293.84 | 290.13 | -- |
| Total Assets | 310.55 | 305.01 | 303.15 | 301.88 | 295.83 | 292.27 | 0.23 |
| Total Current Liabilities | 0.95 | 0.08 | 0.54 | 0.12 | 0.08 | 0.08 | -- |
| Total Non-current Liabilities* | 10.56 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | -- |
| Total Liabilities | 11.51 | 10.14 | 10.61 | 10.18 | 10.14 | 10.14 | 0.25 |
| Retained Earnings | (11.23) | (9.67) | (8.76) | (7.42) | (6.89) | (6.63) | (0.04) |
| Total Stockholder Equity | (11.23) | (9.67) | (8.76) | (7.42) | (6.89) | (6.63) | (0.02) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Selling, General & Admin | 1.15 | 0.40 | 0.92 | 2.34 | 0.28 | 0.25 | 0.26 | 0.30 | 0.02 |
| Total Operating Expenses | -- | -- | -- | -- | 0.03 | 0.00 | 0.00 | 0.04 | -- |
| Operating Income | (1.15) | (0.40) | (0.92) | (2.34) | (0.28) | (0.25) | (0.26) | (0.30) | -- |
| Net Income | 1.49 | 2.68 | 2.32 | 0.84 | 2.71 | 3.29 | 3.56 | 1.96 | (0.02) |
| Basic EPS | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 |
| Diluted EPS | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | (0.33) | (0.18) | (1.25) | (1.79) | (0.19) | (0.14) | (0.12) | (1.06) | 0.00 |
| Investing Cash Flow | -- | 0.00 | 1.00 | -- | -- | 1.00 | 0.00 | (287.50) | -- |
| Financing Cash Flow | 0.50 | -- | -- | -- | -- | 0.00 | 0.00 | 290.23 | -- |
